In a cross-sectional survey presented at the American Academy of Pain Medicine PainConnect 2025 annual meeting in Austin, TX, researchers found that nearly 2 in 5 patients reported inadequate pain relief...
A new study presented at the American College of Foot and Ankle Surgeons Scientific Conference in Phoenix, AZ, found no significant difference in opioid refills between patients receiving liposomal...
A recent study found that patients undergoing knee replacement surgery managed postoperative pain and opioid use effectively, regardless of whether they received education through a webinar, in-person...
The FDA has approved suzetrigine 50 milligram oral tablets for moderate to severe acute pain in adults. The drug acts on the peripheral nervous system before pain signals can reach the brain, eliminating...
Nearly 108,000 Americans died of overdoses in 2022, surpassing the previous year’s record total, according to a CDC report. Although the official number of deaths caused by overdoses—107,941—breaks the...
The FDA approved the second over-the-counter nasal spray with the goal of increasing access to products that can rapidly reverse the effects of opioid overdose.
To guide prevention efforts for fatal poisonings in pediatric patients, the authors of a recent study examined characteristics of death from poisoning in young children within the United States.
In a recent study presented at the Hematology/Oncology Pharmacy Association annual conference, researchers examined the use of opioids in patients with head and neck squamous cell carcinoma while undergoing...
